C7ORF60 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.258400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.818560E-01
Normal-vs-Stage2
2.512400E-01
Normal-vs-Stage3
1.121720E-02
Normal-vs-Stage4
3.626800E-01
Stage1-vs-Stage2
7.625200E-01
Stage1-vs-Stage3
1.600850E-01
Stage1-vs-Stage4
8.772800E-01
Stage2-vs-Stage3
9.753900E-02
Stage2-vs-Stage4
9.539200E-01
Stage3-vs-Stage4
2.213600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.078200E-01
Normal-vs-AfricanAmerican
4.746600E-01
Normal-vs-Asian
2.425600E-01
Caucasian-vs-AfricanAmerican
6.848600E-01
Caucasian-vs-Asian
8.400200E-01
AfricanAmerican-vs-Asian
6.839600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.436400E-01
Normal-vs-Female
2.132200E-01
Male-vs-Female
5.919200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.376600E-01
Normal-vs-Age(41-60Yrs)
5.670800E-01
Normal-vs-Age(61-80Yrs)
1.504820E-01
Normal-vs-Age(81-100Yrs)
3.237700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.933200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.298200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.904990E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.619800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.419600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.371400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.528030E-01
Normal-vs-Daily Drinker
1.278230E-01
Normal-vs-Weekly Drinker
1.237420E-01
Normal-vs-Occasional Drinker
1.883750E-01
Normal-vs-Social Drinker
8.964000E-01
Non Drinker-vs-Daily Drinker
9.236600E-01
Non Drinker-vs-Weekly Drinker
9.745000E-01
Non Drinker-vs-Occasional Drinker
3.532600E-01
Non Drinker-vs-Social Drinker
3.888000E-02
Daily Drinker-vs-Weekly Drinker
9.076000E-01
Daily Drinker-vs-Occasional Drinker
3.081200E-01
Daily Drinker-vs-Social Drinker
4.284100E-02
Weekly Drinker-vs-Occasional Drinker
3.921200E-01
Weekly Drinker-vs-Social Drinker
8.568000E-02
Occasional Drinker-vs-Social Drinker
2.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.952840E-01
Normal-vs-Grade 2
2.536300E-02
Normal-vs-Grade 3
6.100300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.736400E-01
Grade 1-vs-Grade 3
3.303000E-01
Grade 1-vs-Grade 4
1.952840E-01
Grade 2-vs-Grade 3
9.336400E-01
Grade 2-vs-Grade 4
2.536300E-02
Grade 3-vs-Grade 4
6.100300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.490000E-01
Normal-vs-NonDiabetic
1.985820E-01
Diabetic-vs-NonDiabetic
7.522400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.001000E-01
Normal-vs-NoPancreatitis
2.237600E-01
Pancreatitis-vs-NoPancreatitis
8.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.064600E-01
Normal-vs-N1
2.397800E-01
N0-vs-N1
2.535200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.026200E-01
Normal-vs-TP53-NonMutant
2.802400E-01
TP53-Mutant-vs-TP53-NonMutant
6.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
